Colorectal cancer in young: a 5-year study from a sub-Saharan African country Authors: Efared Boubacar, Abani Bako Aïchatou Balaraba, Boubacar Idrissa, Adamou Anza Mahamadou, Salifou Boureima Habiba, Sani Rachid, Nouhou Hassan Published: 2025 ABSTRACT AbstractIntroductionColorectal cancer (CRC) is one of the most frequent malignancies worldwide. There is a global trend in the increase of CRC incidence in younger patients. Our objective is to perform a comparative analysis of CRC in younger patients (˂45 years) and in older patients (≥ 45 years) in a sub-Saharan African country.MethodsOver a period of 5 years, we retrospectively included patients diagnosed with CRC at our Pathology service. We performed statistical comparisons of clinicopathological features between young and older patients with CRC, and searched for risk factors associated with the occurrence of CRC in young patients.ResultsWe identified 173 cases of CRC, ranking as the third most common cancer. The mean age was 49 years ± 16.1 (range of 15–84 years), with young patients representing 39.9% (69 cases). Compared to older patients, CRC was more frequent in young females (43.5% versus 28.8%, P = 0.048). Also, CRC in young patients was often associated with mucinous or signet ring cell (SRC) carcinoma histological differentiation (21.7% versus 5.8%, P = 0.002). Although CRC tended to present in more advanced stages (stages III – IV) in young patients, the difference failed to reach statistical difference (47.6% versus 39.5%, P = 0.596). In univariate logistic regression analysis, female sex (Odds ratio (OR) = 1.9, P = 0.049) and mucinous/SRC histological differentiation (OR = 4.59, P = 0.003) were risk factors associated with the occurrence of CRC in young patients.ConclusionColorectal cancer is a frequent malignancy in our country, affecting a substantial proportion of young persons, emphasizing the need for earlier screening. Young patients with CRC present with adverse clinicopathological features in comparison to older patients.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12876-025-04457-y.Keywords: Colorectal cancer, Carcinoma, Young, Africa Introduction Colorectal cancer (CRC) is one of the most frequent malignancies worldwide, posing a major public health threat [1, 2]. According to the 2022 global cancer statistics CRC was the third most frequent cancer with 1,926,118 new cases, ranking as the second cancer in mortality with 903,859 deaths [1]. Colorectal cancer is most frequent in Western countries with high human development index (HDI) in contrast to countries with low HDI, especially certain African countries where uterine cervix or liver cancers are usually more common [1–3]. Classically CRC is a malignancy of older persons beyond 50–60 years of age, however there is actually a global tendency in increase of CRC incidence in younger patients aged ˂50 years [4–8]. This trend of occurrence of CRC in younger patients (early-onset CRC) is frequently found in Asians and African countries compared to Western countries [5, 9, 10]. Incidence of CRC in young is expected to increase in the coming years, prompting some academic and scientific instances to lower the age of screening from 50 to 45 years in patients with average-risk of CRC [11]. Carcinoma (an epithelial malignant tumor) is the major histological variant of CRC and most studies of CRC in young have focused on this variant [12–15]. These studies showed contradictory differential features between CRC in younger patients and CRC in older patients (late onset-CRC), regarding epidemiological, histopathological, clinical and prognostic aspects [16–20]. Consistent data regarding CRC in young patients are scarce in Sub-Saharan African countries [10, 21, 22], and to the best of our knowledge there were no previous studies regarding comparative analysis of CRC of younger and older patients in our country. The objective of this current study is to perform a comparative clinicopathological study of CRC in younger patients (˂45 years) and in older patients (≥ 45 years). Methods Patients’ selection We retrospectively included all patients diagnosed with CRC at our Pathology laboratory from February 2020 to January 2025 (a period of 5 years). Clinicopathological data were extracted from patients’ pathology request forms and pathology reports. Patients aged ˂45 years were considered young according to some previous studies and with regards to the recommended threshold of CRC screening [10, 11]. Recently, in its update on CRC screening, the United States Multi-Society Task Force on Colorectal Cancer (which represents the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy) suggests average-risk CRC screening begin at age 45. In fact, this recommendation is based on the increasing disease burden among individuals under age 50 [11, 23]. We excluded from the study patients with unknown age, anal cancer, or secondary CRC. Histopathological diagnosis Only patients diagnosed with epithelial malignancies were included (carcinomas). Those with other histological variants of CRC were excluded (especially CRC neuroendocrine tumors, CRC lymphomas and CRC sarcomas). The histopathological diagnosis was performed on formalin-fixed and paraffin-embedded specimens stained by hematoxylin and eosin (H&E).The tumor staging was performed on resected specimens according to the 8th UICC (Union for International Cancer Control) classification system. Statistical analysis Patients were divided in 2 groups: young patients (˂45 years) and old patients (≥ 45 years). Differences in the distribution of clinicopathological variables (categorical variables) between these 2 groups were assessed using the Fisher exact test (when the sample size in subgroups was less than 5) or the chi-square test (when the subgroups sample size ≥ 5). Logistic regression analysis was performed to identify clinicopathological factors associated with the occurrence of CRC in younger patients. All clinicopathological variables have been included in the univariate analysis. The attempt to perform multivariate analysis including variables with P < 0.2 in univariate analysis failed as P = 0.001 after the Hosmer-Lemeshow test assessment. All statistical analyses were performed by using SPSS® 25.0 version software for Windows and the Datatab® online statistical software. A P < 0.05 was considered statistically significant. A part of this study was presented as an oral communication at the XVIIIth DAF/AIP congress (African Francophone Division of the International Academy of Pathology) held in Bangui, Central African Republic from 26 to 28 February 2025. Results Clinicopathological characteristics of our entire cohort (173 patients) Over a period of 5 years we identified 173 cases of CRC, ranking as the third most common cancer diagnosed at our tertiary Pathology laboratory service, after the breast and prostate cancers. The Table 1 summarizes the clinicopathological features of our entire cohort. The mean age was 49 years ± 16.1 (range of 15–84 years), with young patients (˂45 years) representing 39.9% (69 cases). Colorectal cancer was commonly found in age ranges of 50–59 years (20.2%), 60–69 years (19.7%) and 30–39 years (18.5%) (Fig. 1). Males were more affected by CRC than their females counterpart (sex ratio: 113/60 = 1.88). Most tumors were located on the left colon (130/166 cases; 78.3%) (1/3 distal transverse colon, descending colon, sigmoid colon and the rectum). Table 1.Clinicopathological features of the 173 patients with colorectal cancer (CRC)VariablesEffectivePercentage (%)Age (years) (n=173) - Mean±SD49 years ± 16,1- - Young (˂45 years)6939.9% - Old (≥45 years)10460.2%Sexe (n=173) - Female6034.7% - Male11365.3%Specimens (n=173) - Biopsies10963% - Resected specimens6437%Tumor site (n=166) - Right colon3621.7% - Left colon-rectum13078.3%Macroscopic features (n=105) - Ulcerated tumors3331.4% - Fungating tumors7268.6%Histological type (n=173) - Mucinous/SRC carcinomas2112.1% - Other adenocarcinomas15287.9%Vascular invasion (n=64) - Present1117.2% - Absent5382.8%Perineural invasion (n=64) - Present914% - Absent5586%Lymph node invasion (n=64) - Present2539% - Absent3961%pT stage (n=64) - pT1 – pT21625% - pT3 – pT44875%Distant metastases (n=73) - Present1419.2% - Absent5980.8%UICC stage (n=64) - Stages I – II3757.8% - Stages III – IV2742.2% Clinicopathological features of the 173 patients with colorectal cancer (CRC) Age ranges of patients with colorectal cancer (CRC) The diagnosis was performed on 64 resection specimens (73%). The macroscopic features assessed by endoscopic examination or by gross analysis of resected specimens, were ulcerated (31.4%) (Fig. 2) and fungating tumors (68.6%). There were 152 cases (87.9%) of poorly to well differentiated adenocarcinomas (Fig. 3) and 21 cases (12.1) of mucinous and signet ring cell (SRC) carcinomas (Fig. 4A and B). At the time of diagnosis, distant metastases data were available for 73 patients, 14 of whom (19.2%) had metastases. On resected specimens (64 cases), 27 patients (42.2%) were diagnosed with advanced cancer stages (UICC stages III – IV). Right hemicolectomy showing an ulcerated tumor (arrow) on the ascending colon Histological image of a well-differentiated colorectal (CRC) adenocarcinoma showing glandular structures infiltrating the colon wall (Hematoxylin & Eosin x 200) A Histological image of a mucinous colorectal carcinoma consisting of large invasive areas of extracellular mucin (Hematoxylin & Eosin x 100). B A case of CRC with signet ring cell differentiation showing diffuse non-cohesive tumor cells with abundant mucinous cytoplasm and peripheral hyperchromatic nuclei (Hematoxylin & Eosin x 200) Comparative analysis of CRC in young (˂45 years) and old patients (≥ 45 years) The Table 2 summarizes the clinicopathological differential features between young patients with CRC and older ones. Table 2.Differential characteristics of colorectal cancer (CRC) in young (˂ 45 years) and in older patients (≥45 years)VariablesCRC < 45 yearsCRC ≥ 45 yearsP valueSex (n=173) - Female30 (43.5%)30 (28.8%)0.048 - Male39 (56.5%)74 (71.2%)Tumor site (n=166) - Right colon10 (15.4%)26 (25.7%)0.127 - Left colon55 (84.6%)75 (74.3%)Macroscopic features (n=105) - Ulcerated tumors14 (35.9%)19 (28.8%)0.448 - Fungating tumors25 (64.1%)47 (71.2%)Histological type (n=173) - Mucinous/SRC carcinomas15 (21.7%)6 (5.8%)0.002 - Other adenocarcinomas54 (78.3%)98 (94.2%)Vascular invasion (n=64) - Present2 (9.5%)9 (20.9%)0.314⁎ - Absent19 (90.5%)34 (79.1%)Perineural invasion (n=64) - Present3 (14.3%)6 (14%)1.000⁎ - Absent18 (85.7%)37 (86%)pT stage (n=64) - pT1 – pT26 (28.6%)10 (23.3%)0.760 - pT3 – pT415 (71.4%)33 (76.7%)Lymph node metastasis (n=64) - Present10 (47.6%)15 (34.9%)0.416 - Absent11 (52.4%)28 (65.1%)Distant metastasis (n=73) - Present6 (23.1%)8 (17%)0.548 - Absent20 (76.9%)39(83%)Tumor stage (UICC) (n=64) - Stages I – II11 (52.4%)26 (60.5%)0.596 - Stages III – IV10 (47.6%)17 (39.5%)⁎Fisher-exact analysis. The remaining P values correspond to chi-square test Differential characteristics of colorectal cancer (CRC) in young (˂ 45 years) and in older patients (≥45 years) ⁎Fisher-exact analysis. The remaining P values correspond to chi-square test The mean age of young patients with CRC was 32.7 years ± 8.4 (range of 15–44 years). Compared to older patients, CRC was more frequent in young females (43.5% versus 28.8%, p = 0.048). Also, CRC in young patients was often associated with mucinous/SRC histological differentiation (21.7% versus 5.8%, p = 0.002). Tumors in younger patients with CRC were commonly found in the left colo-rectum without significant statistical difference when compared to older patients (84.6% versus 74.3%, p = 0.127). Although CRC tended to present in more advanced stages (stages III – IV) in young patients, the difference failed to reach statistical difference (47.6% versus 39.5%, p = 0.596). In univariate logistic regression analysis, female sex (Odds ratio (OR) = 1.9, P = 0.049) and mucinous/SRC histological differentiation (OR = 4.59, P = 0.003) were risk factors associated with the occurrence of CRC in young patients (Table 3). Table 3Univariate logistic regression analysis of risk factors associated with the occurrence of colorectal cancer (CRC) in young patients (˂45 years)VariablesOdds Ratio95% Confidence IntervalP valueFemale Sex1.91–3.590.049Left side1.520.73–3.140.259Ulcerated tumor1.140.53–2.460.741Mucinous/SRC differentiation4.541.66–12.370.003Presence of vascular invasion0.320.07–1.510.148Presence of perineural invasion0.740.18–3.070.681Advanced pT stage (pT3-pT4)0.600.30–1.210.153Presence of lymph node metastasis1.010.42–2.390.99Presence of distant metastasis1.140.38–3.450.813Advanced tumor stage (stage III-IV)0.870.37–2.030.742 Univariate logistic regression analysis of risk factors associated with the occurrence of colorectal cancer (CRC) in young patients (˂45 years) Discussion Over a 5-year study period, we registered 173 patients with CRC (carcinoma), representing the third most frequent cancer diagnosed at our Pathology department. The 2 most frequent cancers in our service were the breast cancer followed by prostatic cancer. In previous studies in our country, breast and liver cancers were the 2 most common malignancies [1, 3]. However, these studies report data before 2010, when the medical practice were radically different from now: there were no sufficient qualified physicians to perform adequate tissue sampling for accurate histopathological diagnoses (especially gastroenterologists or urologists to perform prostatic biopsies). The data of our national cancer registry are no longer updated, thus the published cancer statistics from the International Agency for Research on Cancer (IARC) were extrapolated from previous non updated cancer data [1]. Our Pathology department is in a tertiary care hospital, and represent the most important public pathology laboratory in the all country, receiving until the year 2023 pathology specimens from all regions of our country. The mean age of our entire cohort was 49 years ± 16,1 and CRC in young patients (< 45 years) represent 39.9%. Many studies find that the prevalence of CRC is higher in black Africans and this cancer affects more younger patients in contrast to white Caucasian people [10, 21, 22, 24]. Although most of these studies considered patients < 50 years as young, in African countries like Burkina Faso [10], Zimbabwe [22], South Africa [21, 24], the proportions of young persons with CRC varied from 30 to 41%. Like in countries with higher HDI [25], CRC is on rise in Sub-Saharan Africa likely due to wider adoption of a western lifestyle, including consumption of meat, sugars, alcohol as well as an increasing urbanization [26]. In European and American countries, the incidence of CRC is increasing in young patients, and the proportions of CRC in young vary from 3.5 to 17% [23, 27–33]. Studies from Asia show the same trend of increasing incidence of CRC in young with a high proportions of CRC in young, around 11 to 41% [5, 9, 15, 16, 18, 34, 35]. We have found that female gender is a risk factor of the occurrence of CRC in young (43.5% versus 28.8%, p = 0.048), multiplying the risk by 1.9 (95% CI = 1–3.59; P = 0.049). The female predominance in CRC in young compared to older patients was rarely reported in the literature [33, 35]. However, we have to acknowledge that strict comparison between studies on CRC in young persons is not always possible because of the variations of the age cut-off in the definition of young patients. These cut-offs may range from < 40 to < 50 years according to studies [10, 12, 31]. We did not find significant statistical difference between CRC in young and CRC in older patients in regard to tumor site or tumor’s gross feature (p ˃0.05). In both CRC subgroups tumors were predominantly left-sided (84.6% and 74.3% in young and older patients respectively) with fungating gross appearance. However, CRC of young is classically more found in the left colon especially the rectum, in comparison with CRC in old persons [7, 12, 16, 36]. Colorectal cancer of young has usually a classical histological features: less differentiated with mucinous or signet ring cell (SRC) morphology according to our findings, similar to previous studies [12, 14, 15, 37, 38]. In our study, mucinous/SRC carcinomas were found in 15 young patients (21.7%) and in 6 older patients (5.8%) with a significant statistical difference (p = 0.002). Also, the mucinous/SRC morphology was strongly associated with the occurrence of CRC in young (OR = 4.54, 95% CI = 1.66–12.37; P = 0.003). However, we did not find significant difference between CRC in young and CRC in older patients, in terms of histoprognostic factors such as perineural invasion, vascular emboli, lymph node invasion, distant metastasis and UICC tumor stage, although younger patients tend to present with more lymph node invasion (47.6% versus 34.9%), distant metastases (23.1% versus 17%) and advanced tumor stage (III – IV) (47.6% versus 39.5%). Unfortunately, due to the retrospective nature of our study and the impossibility to have adequate clinical aspects and follow-up data, we have been unable to provide therapeutic and survival data of our patients. Like our findings, previous studies showed that although CRC of young present with more aggressive clinicopathological features (less differentiated histology, lymph node invasion, distant metastases and advanced clinical stage), its survival rate is quite similar to CRC in older patients [12, 15, 31, 35, 39]. Also molecular histopathological techniques are not available in our country, thus we were not able to report molecular features of our patients. Microsatellite instability (MSI) due to mismatch repair (MMR) genes mutation or hypermethylation, is the common molecular alteration in young with CRC [8, 31, 40, 41]. Most cases of CRC in young are sporadic, although the familial history of CRC is usually found in these patients [15, 31, 42]. In our study, unfortunately we did not have clinical data regarding familial history of our patients. Many unresolved issues remain in the pathogenesis of CRC in young. A recent study on microbiome show that CRC tumors in young were enriched with Akkermansia and Bacteroides, whereas CRC tumors of older patients showed greater relative abundances of Bacillus, Staphylococcus, Listeria, Enterococcus, Pseudomonas, Fusobacterium, and Escherichia/Shigella [20]. Despite monocentric and retrospective, our study has a merit to report some clinicopathological features in a sub-Saharan African context. However more studies including follow-up and molecular data are needed. Conclusion Colorectal cancer is a frequent malignancy in our country, affecting a substantial proportion of young persons, emphasizing the need for earlier screening. Young patients with CRC present with adverse clinicopathological features in comparison to older patients. More studies are needed in our context to shed light on the particular features of CRC in young patients. Supplementary Information Supplementary Material 1 Authors’ contributions All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Efared Boubacar, Abani Bako Aïchatou Balaraba, Boubacar Idrissa, Adamou Anza Mahamadou, Salifou Boureima Habiba, Sani Rachid and Nouhou Hassan. The first draft of the manuscript was written by Efared Boubacar and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. Funding No funds, grants, or other support was received. Data availability The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Hôpital National de Niamey (1st September 2023/No. 00169/DGHNN/DAF/SGRH). As a retrospective study with de-identified data, the consent for publication was waived by the Ethics Committee of Hôpital National de Niamey (ref: 1 st September 2023/No. 00169/DGHNN/DAF/SGRH). Consent for publication Not Applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.